COMMUNIQUÉS West-GlobeNewswire

MVZ Prof. Dr. Uhlenbrock and Partner decides for C-RAD’s innovative SIGRT solution
17/07/2019
C-RAD announced today an order for its surface tracking solution based on Catalyst HD™ and Sentinel 4DCT™ for MVZ Prof. Dr. Uhlenbrock and Partner GmbH in Dortmund Germany. MVZ Uhlenbrock & Partner GmbH is a [...]
Orion Group Half-Year Financial Report January–June 2019
17/07/2019
ORION CORPORATION HALF-YEAR FINANCIAL REPORT JANUARY–JUNE 2019 17 JULY 2019 at 12.00 EEST Orion Group Half-Year Financial Report January–June 2019 Net sales in January–June 2019 totalled EUR 493 million (EUR 493 million [...]
Orion Corporation's financial reporting and Annual General Meeting in 2020
17/07/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 17 JULY 2019 at 11.00 a.m. EEST Orion Corporation's financial reporting and Annual General Meeting in 2020 Orion Corporation will publish its Financial Statement Release 2019 on [...]
AgraFlora Organics Expands Cannabinoid-Infused Cosmetics/Topicals Distribution to Continental US; Whole Hemp Health Personal Care Line Now Available in 20+ Brick and Mortar Locations Across Canada
17/07/2019
VANCOUVER, British Columbia, July 17, 2019 (GLOBE NEWSWIRE) -- Vancouver, British Columbia / July 17 th , 2019 – AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) ( [...]
Notice of extra general meeting in Acarix AB
17/07/2019
Press release July 17, 2019 Notice of extra general meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the " Company "), are hereby convened to the extra general meeting to be held on Friday 16 [...]
Nicox: Second Quarter 2019 Business Update and Financial Highlights
17/07/2019
Press Release Nicox: Second Quarter 2019 Business Update and Financial Highlights Enrollment completed in the NCX 470 Phase 2 clinical trial in patients with glaucoma and ocular hypertension with results expected in [...]
Nicox : Point d’activité et résumé financier du deuxième trimestre 2019
17/07/2019
Communiqué de presse Nicox : Point d’activité et résumé financier du deuxième trimestre 2019 Recrutement terminé dans l’étude clinique de phase 2 sur le NCX 470 pour le glaucome et l’hypertension oculaire. Premiers [...]
Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPF
17/07/2019
Study expands potential clinical indications for lead compound Trial fully funded via a grant from the United States National Institutes of Health ARCHAMPS, France, July 17, 2019 (GLOBE NEWSWIRE) -- Genkyotex (Euronext [...]
Genkyotex annonce l'approbation par la FDA de l'essai de Phase 2 avec le GKT831 dans la fibrose pulmonaire
17/07/2019
Cette étude élargit les indications cliniques potentielles pour ce composé phare Essai financé par une subvention des National Institutes of Health aux États-Unis ARCHAMPS, France, 17 juill. 2019 (GLOBE NEWSWIRE) -- [...]
First Publication from OSE Immunotherapeutics on the Role of SIRPα in the Induction and Maintenance of Immune Tolerance in the American Journal of Transplantation
17/07/2019
Findings show the role of the SIRPα/CD47 axis in the maintenance of acquired immune tolerance Highlights the differentiated mechanism of action of OSE's innovative myeloid checkpoint inhibitor BI 765063 (OSE-172), a [...]
Repligen Corporation Announces Pricing of Public Offerings of $120 million of Common Stock and $250 million of 0.375% Convertible Senior Notes due 2024
17/07/2019
WALTHAM, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced the pricing of concurrent underwritten public offerings of 1,380,000 shares of its common stock (the “ [...]
Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
17/07/2019
VANCOUVER, British Columbia, July 16, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Immuron Announces Proposed Public Offering of ADSs
16/07/2019
MELBOURNE, Australia, July 16, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for [...]
Cytori Will Become Plus Therapeutics, Inc.
16/07/2019
Plus Therapeutics Reflects A New Focus On Developing Innovative Drugs AUSTIN, Texas, July 16, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) (the “company”) announced yesterday a new direction and [...]
BeyondSpring Announces Proposed Public Offering of Ordinary Shares
16/07/2019
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global clinical stage biopharmaceutical company focused on the development and commercialization of [...]
Wright Medical Group N.V. to Host Second Quarter 2019 Earnings Conference Call
16/07/2019
Wednesday, August 7, 2019 at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, July 16, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it will host a conference [...]
Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering
16/07/2019
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock
16/07/2019
MENLO PARK, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV), a clinical stage immuno-oncology company, today announced that it has commenced an underwritten public offering of $75,000,000 of [...]
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 2019
16/07/2019
LYON, France and CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP) announced that its 2019 Annual General Meeting was held in Paris on Friday, June 21, 2019. At the [...]

Pages